Cubist Systematic Strategies’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.86M Sell
16,800
-16,300
-49% -$1.85M 0.01% 1604
2025
Q2
$3.67M Buy
33,100
+21,600
+188% +$2.3M 0.02% 1213
2025
Q1
$1.29M Buy
11,500
+8,700
+311% +$898K 0.01% 1681
2024
Q4
$259K Hold
2,800
﹤0.01% 2465
2024
Q3
$235K Buy
2,800
+1,900
+211% +$145K ﹤0.01% 2519
2024
Q2
$61.7K Sell
900
-14,500
-94% -$968K ﹤0.01% 2688
2024
Q1
$1.13M Sell
15,400
-6,700
-30% -$515K 0.01% 2075
2023
Q4
$1.79M Buy
22,100
+19,200
+662% +$1.49M 0.01% 1612
2023
Q3
$217K Sell
2,900
-17,000
-85% -$1.31M ﹤0.01% 2744
2023
Q2
$1.53M Sell
19,900
-101,200
-84% -$8.07M 0.01% 1685
2023
Q1
$10M Sell
121,100
-12,600
-9% -$1.04M 0.06% 453
2022
Q4
$11.5M Buy
133,700
+97,000
+264% +$7.68M 0.07% 404
2022
Q3
$2.26M Buy
36,700
+10,000
+37% +$631K 0.01% 1880
2022
Q2
$1.65M Buy
+26,700
New +$1.65M 0.01% 2026

Other funds holding GILD

Cubist Systematic Strategies's GILD Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 50,395 shares — an estimated $5.73M sold.

Cubist Systematic Strategies first reported a position in GILD in Q2 2014 and held it in 43 quarters. The position peaked at $41.4M in Q4 2022. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 50,395 Gilead Sciences shares in Q3 2025, an estimated $5.73M.
  • Cubist Systematic Strategies first reported a position in Gilead Sciences in Q2 2014 and held it in 43 quarters.
  • Cubist Systematic Strategies's Gilead Sciences position peaked at $41.4M in Q4 2022.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.